Ben Venue Laboratories Inc recalls CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by Bedford Laboratories, B
Recalled August 27, 2014 · FDA recall D-1543-2014 · Ben Venue Laboratories
Hazard
Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity. · FDA Class II
Units
7172 vials
Sold at
Nationwide
Description
Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.
Product
CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by Bedford Laboratories, Bedford, OH 44146, Manufactured by Ben Venue Labs, Inc., Bedford, OH 44146, NDC 55390-808-01
Manufacturer(s)
Ben Venue Laboratories Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →